Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1786 1
1795 1
1797 1
1799 1
1814 1
1816 1
1818 1
1819 1
1822 2
1824 1
1828 3
1829 1
1830 2
1831 2
1832 2
1833 2
1834 1
1835 1
1837 1
1840 3
1841 7
1842 4
1843 3
1844 4
1845 5
1846 9
1847 5
1848 2
1849 2
1850 4
1851 3
1852 6
1853 4
1854 1
1855 2
1856 4
1857 2
1858 1
1859 1
1860 3
1861 2
1862 1
1864 2
1866 4
1867 8
1868 4
1869 3
1870 3
1871 1
1872 11
1873 4
1874 12
1875 7
1876 5
1877 6
1878 14
1879 2
1880 5
1881 10
1882 8
1883 11
1884 9
1885 7
1886 4
1887 10
1888 9
1889 7
1890 7
1891 3
1892 10
1893 7
1894 18
1895 12
1896 12
1897 20
1898 23
1899 23
1900 9
1901 28
1902 18
1903 9
1904 25
1905 31
1906 15
1907 21
1908 23
1909 29
1910 16
1911 34
1912 23
1913 26
1914 24
1915 18
1916 25
1917 30
1918 26
1919 14
1920 12
1921 27
1922 24
1923 32
1924 28
1925 40
1926 29
1927 33
1928 34
1929 35
1930 45
1931 43
1932 31
1933 41
1934 33
1935 42
1936 31
1937 37
1938 33
1939 26
1940 38
1941 30
1942 20
1943 19
1944 15
1945 208
1946 598
1947 750
1948 850
1949 808
1950 1257
1951 1467
1952 1520
1953 1663
1954 1773
1955 1907
1956 1964
1957 2161
1958 2037
1959 2113
1960 2169
1961 2494
1962 2753
1963 3999
1964 5915
1965 5248
1966 5587
1967 6684
1968 8289
1969 9483
1970 9572
1971 10418
1972 11027
1973 11176
1974 11710
1975 11364
1976 10655
1977 10626
1978 10702
1979 11201
1980 11398
1981 10945
1982 10918
1983 11347
1984 12074
1985 12548
1986 12498
1987 13355
1988 13633
1989 15136
1990 14947
1991 15229
1992 15433
1993 15697
1994 16165
1995 16265
1996 17108
1997 16948
1998 17174
1999 16815
2000 17222
2001 17738
2002 18799
2003 19731
2004 20915
2005 22442
2006 23373
2007 24188
2008 25972
2009 26769
2010 28025
2011 30273
2012 33340
2013 33609
2014 34579
2015 35368
2016 36114
2017 36705
2018 37598
2019 39268
2020 45210
2021 48903
2022 46372
2023 44306
2024 16320

Text availability

Article attribute

Article type

Publication date

Search Results

1,144,831 results

Results by year

Filters applied: . Clear all
Page 1
Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.
Provenzano R, Shutov E, Eremeeva L, Korneyeva S, Poole L, Saha G, Bradley C, Eyassu M, Besarab A, Leong R, Liu CS, Neff TB, Szczech L, Yu KP. Provenzano R, et al. Nephrol Dial Transplant. 2021 Aug 27;36(9):1717-1730. doi: 10.1093/ndt/gfab051. Nephrol Dial Transplant. 2021. PMID: 33629100 Clinical Trial.
BACKGROUND: We evaluated the efficacy and safety of roxadustat versus epoetin alfa for the treatment of chronic kidney disease-related anemia in patients new to dialysis. ...Roxadustat was non-inferior [least squares mean difference: 0.18 (95% CI 0.08, 0.29)] …
BACKGROUND: We evaluated the efficacy and safety of roxadustat versus epoetin alfa for the treatment of chronic kidney …
ERYTHROPOIETIN.
LANGE RD, PAVLOVIC-KENTERA V. LANGE RD, et al. Prog Hematol. 1964;4:72-96. Prog Hematol. 1964. PMID: 14274541 Review. No abstract available.
Erythropoietin in Friedreich ataxia.
Mariotti C, Nachbauer W, Panzeri M, Poewe W, Taroni F, Boesch S. Mariotti C, et al. J Neurochem. 2013 Aug;126 Suppl 1:80-7. doi: 10.1111/jnc.12301. J Neurochem. 2013. PMID: 23859343 Free article. Review.
Evidence for recombinant human erythropoietin (rHuEPO) in FRDA is based on in vitro studies using mouse neuronal cell lines, human fibroblasts, cardiomyocytes, and primary lymphocytes from FRDA patients or control subjects which showed a dose-dependent increase of frataxin …
Evidence for recombinant human erythropoietin (rHuEPO) in FRDA is based on in vitro studies using mouse neuronal cell lines, human fi …
The Latest Evidence of Erythropoietin in the Treatment of Glaucoma.
Lin TY, Lai YF, Chen YH, Lu DW. Lin TY, et al. Int J Mol Sci. 2022 Dec 16;23(24):16038. doi: 10.3390/ijms232416038. Int J Mol Sci. 2022. PMID: 36555679 Free PMC article. Review.
Erythropoietin (EPO) is a circulating hormone conventionally considered to be responsible for erythropoiesis. ...
Erythropoietin (EPO) is a circulating hormone conventionally considered to be responsible for erythropoiesis. ...
Erythropoiesis-Stimulating Agents and Mortality.
Drüeke TB, Massy ZA. Drüeke TB, et al. J Am Soc Nephrol. 2019 Jun;30(6):907-908. doi: 10.1681/ASN.2019030266. Epub 2019 Apr 23. J Am Soc Nephrol. 2019. PMID: 31015256 Free PMC article. No abstract available.
Erythropoietin preserves the integrity and quality of organs for transplantation after cardiac death.
Maio R, Sepodes B, Patel NS, Thiemermann C, Mota-Filipe H, Costa P. Maio R, et al. Shock. 2011 Feb;35(2):126-33. doi: 10.1097/SHK.0b013e3181e83236. Shock. 2011. PMID: 20523268
EPO 30 min before cardiac arrest. Kidneys were then subjected to 30 min of warm ischemia and were transplanted after 24 h of cold storage. Renal dysfunction, injury, and inflammation were evaluated 4 h after transplantation. Transplantation of kidne …
EPO 30 min before cardiac arrest. Kidneys were then subjected to 30 min of warm ischemia and were transplanted after 24 h of c …
Effects of ganglioside GM1 and erythropoietin on spinal cord injury in mice: Functional and immunohistochemical assessments.
Torelli AG, Cristante AF, de Barros-Filho TEP, Dos Santos GB, Morena BC, Correia FF, Paschon V. Torelli AG, et al. Clinics (Sao Paulo). 2022 Feb 19;77:100006. doi: 10.1016/j.clinsp.2022.100006. eCollection 2022. Clinics (Sao Paulo). 2022. PMID: 35193085 Free PMC article.
OBJECTIVES: To evaluate the functional and immunohistochemical effects of ganglioside GM1 and erythropoietin following experimental spinal cord injury. METHODS: Thirty-two male BALB/c mice were subjected to experimental spinal cord injury using the NYU Impactor device and …
OBJECTIVES: To evaluate the functional and immunohistochemical effects of ganglioside GM1 and erythropoietin following experimental s …
Biosimilar Erythropoiesis-Stimulating Agents in Chronic Kidney Disease.
Shah HH, Fishbane S. Shah HH, et al. Adv Chronic Kidney Dis. 2019 Jul;26(4):267-271. doi: 10.1053/j.ackd.2019.04.007. Adv Chronic Kidney Dis. 2019. PMID: 31477257 Review.
Anemia is a well-known complication of advanced CKD and treatment with erythropoietin analogues (epoetin) remains a key component of management. ...As a result, several biosimilar agents have now been approved by the U.S. Food and Drug Administration. Biosimilar …
Anemia is a well-known complication of advanced CKD and treatment with erythropoietin analogues (epoetin) remains a key compon …
Iron therapy in chronic kidney disease: Recent changes, benefits and risks.
Ribeiro S, Belo L, Reis F, Santos-Silva A. Ribeiro S, et al. Blood Rev. 2016 Jan;30(1):65-72. doi: 10.1016/j.blre.2015.07.006. Epub 2015 Aug 18. Blood Rev. 2016. PMID: 26342303 Review.
Anemia is a common complication in patients with chronic kidney disease (CKD), mainly due to inadequate renal production of erythropoietin. ...
Anemia is a common complication in patients with chronic kidney disease (CKD), mainly due to inadequate renal production of erythr …
1,144,831 results
You have reached the last available page of results. Please see the User Guide for more information.